Home > Insider Trading > Filing (0001209191-17-045270)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628738	Audentes Therapeutics Inc.	BOLD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1401018	R Matthew Patterson	C/O Audentes Therapeutics, Inc. 600 California Street, 17Th Floor San Francisco CA 94108	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-07-12	2,850	$20.00	198,964	No	4	S	Indirect	By Matthew R. Patterson Revocable Trust
Common Stock	Disposition	2017-07-13	12,150	$20.00	186,814	No	4	S	Indirect	By Matthew R. Patterson Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Matthew R. Patterson Revocable Trust
No	4	S	Indirect	By Matthew R. Patterson Revocable Trust

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
Represents the average weighted sale price. The lowest price at which shares were sold was $20.00 and the highest price at which shares were sold was $20.03. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.
The reporting person is the trustee of the Matthew R. Patterson Revocable Trust.
Represents the average weighted sale price. The lowest price at which shares were sold was $20.00 and the highest price at which shares were sold was $20.06.